openPR Logo
Press release

OTC Consumer Healthcare Market Sales to Top US$ 250 Bn by 2031|Key Players- Merck & Co., Inc., Ceva Sante Animale

07-15-2022 11:08 AM CET | Health & Medicine

Press release from: Persistence Market Research

/ PR Agency: Persistence Market Research
OTC Consumer Healthcare 2022

OTC Consumer Healthcare 2022

OTC Consumer Healthcare 2022

OTC Consumer Healthcare Market to Surpass US$ 250 Bn by 2030; COVID-19 Outbreak Catalyzing Sales of OTC Drugs

With rising ownership of companion animals and pets across the world, both, the pet food and pet medication markets have been thriving. As per the American Pet Products Association, Inc. (APPA), in 2019, U.S. pet expenditure was US$ 95.7 Bn, among which, supplies, live animals, and OTC medicines were worth US$ 19.2 Bn.

Get Sample Copy of This report@https://www.persistencemarketresearch.com/samples/31512

A lot of pets experience health concerns such as arthritis, flee issues, skin allergies, worm-related problems, etc., which can be cured by OTC drugs. This, in turn, is propelling the growth of the OTC pet medication market across the globe.

On the back of these factors, the OTC pet medication market is projected to expand around 1.5 times in current size by the year 2030, progressing at a CAGR of more than 4% over the forecast period of 2020-2030.

Key Takeaways of Global OTC Pet Medication Market Study

There are less number of players having a significant share in the global OTC pet medication market. These prominent players considerably focus on product innovation with natural ingredients, and new product launches.

Manufacturers are incorporating various technological advancements and introducing new formulations such as anti-infective and antiparasitic OTC pet medication to meet the growing demand for safe OTC pet medication.

Most OTC pet medication is demanded for dogs, cats, birds, and fish & reptiles; these held around 87% of the total OTC pet medication market share in 2019.

North America and Europe are the top regions when it comes to pet ownership, which is why they lead in terms of share in the global OTC pet medication market.

Restrictions and lockdowns across the world due to the Covid-19 pandemic have resulted in disruptions in the supply chain of the OTC pet medication market, compounded by production and raw material procurement issues.

"Prominent companies in the OTC pet medication market can gain significant market share by introducing natural medicines for pets. A few companies have already started, even though it is a new concept; hence, the opportunity lies, especially in emerging markets," says a PMR analyst.

Request For Customization@https://www.persistencemarketresearch.com/request-customization/31512

Key Players in OTC Pet Medication Market

PMR's report underlines groundbreaking insights into the competitive scenario of the OTC pet medication market, along with highlights of the differential strategies used by manufacturers. Some of the key players identified across the value chain of the global OTC pet medication market include Boehringer Ingelheim International GmbH, Merck & Co., Inc., Ceva Sante Animale, Bayer Companion Animal, , Zoetis Inc., Virbac SA, Vetoquinol SA, Frontline, Elanco, and others.

Trend of Selling OTC Consumer Healthcare through Mobile Apps & Websites to Fuel Growth

The self-care concept is positively influencing the growth of the global OTC consumer healthcare market, as preference for over-the-counter drugs as an immediate action for minor ailments is rising. Different factors such as convenience, immediacy of action, and avoiding embarrassment are driving the growth of oral healthcare, medicated skin care, dietary supplements, emergency contraceptives, and other OTC products.

Governments across different regions are educating and empowering patients to take charge and control of their own health. According to various independent studies, more than 75% of ailments experienced by people in developed regions are dealt with by the patients themselves, despite having a good system in place. When it comes to self-care, OTC consumer healthcare plays a major role.  

Buy Now@https://www.persistencemarketresearch.com/checkout/31512

PMR's report underlines groundbreaking insights into the competitive scenario of the OTC consumer healthcare market, along with highlights of key players' focus on innovative and differential strategies. Some of the companies holding significant share in the global OTC consumer healthcare market are Sun Pharmaceutical Industries Limited, Glenmark Pharmaceuticals Ltd., Johnson & Johnson Private Ltd, Pfizer, Inc., American Health Corporation, Abbott Laboratories Inc, GlaxoSmithKline plc, Sanofi S.A., Piramal Enterprises Ltd., Boehringer Ingelheim GmbH, Bayer AG, Teva Pharmaceutical Industries Ltd, Ipsen SA, BASF SE, Koninklijke DSM N.V., Reckitt Benckiser LLC, Lonza Group Ltd., and others.

Related Reports- 

Cell Tissue Culture Supplies Market - https://www.persistencemarketresearch.com/market-research/cell-tissue-culture-supplies-market.asp

Disposable Plastic Blood Bag Market - https://www.persistencemarketresearch.com/market-research/disposable-plastic-blood-bag-market.asp

Media Contact:

Persistence Market Research
305 Broadway,7th Floor New York City, NY 10007 United States
Call +1-646-568-7751
Call +1 800-961-0353
sales@persistencemarketresearch.com

About PersistenceMarketResearch:

PersistenceMarketResearch is an esteemed company with a reputation of serving clients across domains of information technology (IT), healthcare, and chemicals. Our analysts undertake painstaking primary and secondary research to provide a seamless report with a 360 degree perspective. Data is compared against rep/uted organizations, trustworthy databases, and international surveys for producing impeccable reports backed with graphical and statistical information.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release OTC Consumer Healthcare Market Sales to Top US$ 250 Bn by 2031|Key Players- Merck & Co., Inc., Ceva Sante Animale here

News-ID: 2681214 • Views:

More Releases from Persistence Market Research

North America Wiring Devices Market Projected to Reach USD 26.46 Billion by 2031
North America Wiring Devices Market Projected to Reach USD 26.46 Billion by 2031
Overview of the North America Wiring Devices Market The North America wiring devices market is poised for steady growth over the forecast period, with its size estimated at US$ 18.96 billion in 2024, projected to reach US$ 26.46 billion by 2031, reflecting a CAGR of 4.9%. The market is witnessing substantial expansion due to increasing urbanization, a rising number of residential and commercial construction projects, and the adoption of energy-efficient and
Global Forged Automotive Components Market Poised for Steady Growth, Projected to Reach US$ 70.7 Billion by 2032
Global Forged Automotive Components Market Poised for Steady Growth, Projected t …
The global forged automotive components market is on a robust growth trajectory, currently valued at approximately US$ 50.3 billion in 2025 and forecasted to expand to US$ 70.7 billion by the end of 2032. This growth represents a compound annual growth rate (CAGR) of 5.0% over the coming decade, driven by increasing automotive production, technological advancements, and evolving consumer preferences toward durable, high-performance vehicle parts. Forged automotive components are critical to
Global Electric Cargo Bike Market Set to Accelerate at 11.9% CAGR, Reaching US$ 2.14 Billion by 2032, Reports Persistence Market Research
Global Electric Cargo Bike Market Set to Accelerate at 11.9% CAGR, Reaching US$ …
The global electric cargo bike market is set to experience substantial growth over the coming decade, with Persistence Market Research (PMR) forecasting a compound annual growth rate (CAGR) of 11.9% from 2023 through 2032. Valued at approximately US$ 800 million in 2021, the market is expected to surge to a projected valuation of US$ 2.14 billion by the end of 2032. Notably, electric cargo bikes accounted for 66.2% of the
Bicycle Bearings Market Set for Steady Growth with 6.5% CAGR Through 2032, Driven by Urbanization and Demographic Trends
Bicycle Bearings Market Set for Steady Growth with 6.5% CAGR Through 2032, Drive …
The global bicycle bearings market is poised for significant expansion over the forecast period of 2025 to 2032, according to the latest report released by Persistence Market Research. Valued at approximately US$ 5.99 billion in 2024, the market is projected to reach US$ 6.35 billion by 2025 and further escalate to nearly US$ 9.86 billion by 2032. This growth trajectory reflects a compound annual growth rate (CAGR) of 6.5%, underscoring

All 5 Releases


More Releases for OTC

Lawsuit filed for Investors who lost money with shares of adidas AG (OTC: ADDYY, …
An investor, who purchased shares of adidas AG (OTC: ADDYY, OTC: ADDDF), filed a lawsuit over alleged violations of Federal Securities Laws by adidas AG in connection with certain allegedly false and misleading statements. Investors who purchased shares of adidas AG (OTC: ADDYY, OTC: ADDDF) have certain options and for certain investors are short and strict deadlines running. Deadline: June 27, 2023. adidas AG (OTC: ADDYY, OTC: ADDDF) investors should contact
Investigation for Investors in adidas AG (OTC: ADDYY, OTC: ADDDF) announced over …
An investigation on behalf of investors in shares of adidas AG (OTC: ADDYY, OTC: ADDDF) was announced over potential breaches of fiduciary duties by certain officers and directors at adidas AG. Investors who purchased shares of adidas AG (OTC: ADDYY, OTC: ADDDF) have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm concerns whether certain adidas AG officers and
AMERICAN HEMP VENTURES INC (OTC: AMHV) TO BECOME YOUNEEQAI TECHNICAL SERVICES In …
FOR IMMEDIATE RELEASE Denver Colorado, March 31, 2023, American Hemp Ventures, Inc. (OTC: AMHV) announced today that its name has changed effective immediately to YouneeqAI Technical Services inc. (OTC: YQAI) reflecting the Company's new focus into cookie-less AI technology services. The current management team has over 50 years of experience in technology services and innovation. Murray Galbraith, YQAI's CEO, is the Founder of YouneeqAI's software solution and has operated several private technology
Investigation announced for Investors who lost money with shares of adidas AG (O …
An investigation was announced for investors of adidas AG (OTC: ADDYY, OTC: ADDDF) shares over potential securities laws violations by adidas AG. Investors who purchased shares of adidas AG (OTC: ADDYY, OTC: ADDDF), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm focuses on possible claims on behalf of purchasers of the securities of adidas AG (OTC: ADDYY,
Fuel Cell Market Technological Trends and Business Opportunities 2021 To 2026; P …
MarketInsightsReports has published a report titled global Fuel Cell Market research report 2021 that is a detailed observation of several aspects, including the rate of growth, technological advances, and different methodologies implemented by the primary current market players. The report is based on a collective analysis of data, which is obtained through primary and secondary research. It provides a systematic approach to the current and prospective scenario of this market. The
Deadline on Nov. 9th upcoming in Lawsuit for Investors in Harborside Inc. (OTC: …
The Shareholders Foundation announced that a deadline is coming up on November 9, 2020 in the lawsuit filed for certain investors of Harborside Inc. (OTC: HSDEF, OTC: HBORF). Investors who purchased shares of Harborside Inc. (OTC: HSDEF, OTC: HBORF) have certain options and there are strict and short deadlines running. Deadline: November 9, 2020. Harborside Inc. stockholders should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. According to